If you or someone you care about has been diagnosed with advanced kidney cancer, finding an effective treatment after previous therapies have stopped working can feel overwhelming. At Unit Pharmacy, we understand the challenges patients and caregivers face while searching for trusted, affordable cancer medications. That’s why we’re committed to helping patients access genuine oncology medicines like Tivoxen 1.34 MG (Tivozanib) with professional guidance and reliable international delivery.
Tivoxen 1.34 MG is an oral targeted therapy containing tivozanib, a highly selective vascular endothelial growth factor receptor (VEGFR) inhibitor. It is the generic equivalent of Fotivda® and is specifically developed to treat adults with advanced renal cell carcinoma (RCC) who have previously received other systemic cancer treatments.
Unlike conventional chemotherapy, Tivoxen works by targeting the blood vessels that feed cancer cells, helping slow disease progression while minimizing damage to healthy cells.
What Is Tivoxen 1.34 MG?
Tivoxen 1.34 MG is an oral anticancer capsule that contains tivozanib, a targeted tyrosine kinase inhibitor (TKI). It belongs to a newer generation of cancer medicines designed to interrupt the signals tumors need to grow and develop new blood vessels.
Because kidney tumors rely heavily on new blood vessel formation to survive, blocking these pathways can significantly slow tumor growth and disease progression.
Tivoxen is prescribed only under the supervision of experienced oncologists and is generally recommended for patients whose cancer has progressed despite previous treatments.
What Is Tivoxen 1.34 MG Used For?
The primary indication for Tivoxen 1.34 MG is:
Advanced Renal Cell Carcinoma (RCC)
Renal Cell Carcinoma is the most common form of kidney cancer in adults. When detected at an advanced stage, the cancer may spread beyond the kidneys to other organs, making treatment more challenging.
Tivoxen helps:
- Slow tumor growth
- Delay cancer progression
- Reduce the development of new blood vessels feeding the tumor
- Improve disease control in advanced kidney cancer
Relapsed or Refractory Kidney Cancer
Your oncologist may recommend Tivoxen if your cancer:
- Returned after previous treatment (relapsed)
- Did not respond adequately to earlier therapies (refractory)
- Continued progressing after immunotherapy
- Progressed after targeted therapies such as VEGF inhibitors
Many patients receive Tivoxen after completing at least two prior systemic treatment regimens.
How Does Tivoxen 1.34 MG Work?
The active ingredient, tivozanib, selectively blocks three important receptors:
- VEGFR-1
- VEGFR-2
- VEGFR-3
These receptors play a critical role in angiogenesis, the process by which tumors create new blood vessels to obtain oxygen and nutrients.
When these receptors are blocked, several important effects occur:
Prevents New Blood Vessel Formation
Tumors cannot easily build new blood vessels.
Starves Cancer Cells
Reduced blood flow limits oxygen and nutrient delivery.
Slows Tumor Growth
Cancer cells lose one of their major survival mechanisms.
Helps Control Disease Progression
Blocking angiogenesis can delay the spread of advanced kidney cancer.
Because Tivoxen specifically targets VEGF receptors, it often causes fewer widespread side effects than traditional chemotherapy.
Benefits of Tivoxen 1.34 MG
Tivoxen offers several advantages for eligible patients:
- Highly targeted therapy
- Oral capsule taken at home
- Helps delay disease progression
- Effective after previous treatments have failed
- Selective VEGFR inhibition may improve tolerability
- Convenient treatment schedule
- Avoids regular intravenous infusions
For many patients with advanced RCC, Tivoxen provides another important treatment option when standard therapies are no longer effective.
Recommended Dosage and Administration
Always follow your oncologist’s instructions.
Standard Treatment Cycle
| Treatment Phase | Schedule |
| Dose | 1 capsule (1.34 MG) once daily |
| Treatment Period | Treatment Period |
| Rest Period | 7 days without medication |
| Total Cycle | 28 days |
Treatment continues as long as your doctor determines you are benefiting and side effects remain manageable.
How to Take Tivoxen
For best results:
- Swallow capsules whole with water.
- Take once daily.
- Can be taken with or without food.
- Do not crush, chew, or open the capsule.
- Take your dose at approximately the same time every day.
Maintaining a consistent schedule helps keep drug levels stable in your body.
Missed Dose Instructions
If you forget to take a dose:
- Skip the missed dose.
- Take your next scheduled dose at the regular time.
- Never take two capsules together to make up for a missed dose.
If vomiting occurs after taking a dose, do not take another capsule unless instructed by your oncologist.
Possible Side Effects of Tivoxen 1.34 MG
Like all targeted cancer therapies, Tivoxen may cause side effects. Many are manageable with supportive care and regular monitoring.
Common Side Effects
Patients commonly report:
- High blood pressure (hypertension)
- Fatigue
- Weakness
- Diarrhea
- Nausea
- Vomiting
- Reduced appetite
- Mouth sores
- Hoarseness
- Hand-foot skin reactions
- Weight loss
Most side effects are mild to moderate and improve with appropriate medical management.
Serious Side Effects
Seek immediate medical attention if you experience:
- Severe or uncontrolled high blood pressure
- Persistent vomiting or diarrhea
- Signs of dehydration
- Chest pain
- Difficulty breathing
- Heavy bleeding
- Blood clots
- Severe headaches
- Sudden vision changes
Your doctor may temporarily interrupt treatment, reduce the dose, or discontinue therapy if severe adverse reactions occur.
Monitoring During Treatment
Regular monitoring is essential throughout treatment with Tivoxen.
Your healthcare team may perform:
- Blood pressure monitoring
- Complete blood count (CBC)
- Liver function tests
- Kidney function tests
- Urine protein testing
- Thyroid function assessment
- Imaging scans to evaluate treatment response
Routine follow-up visits allow your oncologist to ensure the medication remains both safe and effective.
Important Safety Information
Before starting Tivoxen, inform your healthcare provider if you have:
- High blood pressure
- Heart disease
- Kidney disease
- Liver problems
- Bleeding disorders
- Recent surgery
- History of blood clots
- Thyroid disorders
Also provide a complete list of:
- Prescription medicines
- Over-the-counter medications
- Vitamins
- Herbal supplements
Drug interactions can affect both the safety and effectiveness of treatment.
Pregnancy and Breastfeeding
Tivoxen may cause harm to an unborn baby.
Women should:
- Avoid becoming pregnant during treatment.
- Use effective contraception during therapy and for the period recommended by their oncologist after treatment ends.
- Avoid breastfeeding while receiving Tivoxen.
Discuss family planning with your cancer specialist before starting therapy.
Who Should Use Tivoxen 1.34 MG?
Tivoxen is generally appropriate for adults with:
- Advanced renal cell carcinoma
- Metastatic kidney cancer
- Relapsed RCC
- Refractory RCC
- Disease progression after immunotherapy
- Failure of previous targeted therapies
Only an oncologist can determine whether Tivoxen is the right treatment for your individual condition.
Why Choose Tivoxen 1.34 MG?
Targeted therapies have transformed the treatment of advanced kidney cancer.
Compared with traditional chemotherapy, Tivoxen offers several important advantages:
- Precisely targets cancer-related pathways
- Blocks tumor blood vessel formation
- Helps delay disease progression
- Oral treatment that can be taken at home
- Suitable for patients previously treated with other therapies
- Well-established mechanism of action
These benefits make Tivoxen an important option in modern renal cell carcinoma management.
Why Buy Tivoxen 1.34 MG from Unit Pharmacy?
At Unit Pharmacy, we understand that timely access to genuine cancer medications is critical. Our goal is to make the process as simple, transparent, and reliable as possible for patients around the world.
When you choose Unit Pharmacy, you benefit from:
- Genuine, quality-assured oncology medicines
- Competitive international pricing
- Secure worldwide shipping
- Dedicated customer support
- Professional assistance with prescription requirements
- Safe and discreet packaging
Whether you’re purchasing for yourself or a loved one, our team is committed to supporting you throughout the ordering process with care and compassion.
FAQs
1. Is Tivoxen 1.34 MG chemotherapy?
Ans: No. Tivoxen is a targeted therapy known as a tyrosine kinase inhibitor (TKI), not traditional chemotherapy.
2. What type of cancer does Tivoxen treat?
Ans: It is primarily used to treat advanced or metastatic renal cell carcinoma (kidney cancer).
3. Can Tivoxen be taken with food?
Ans: Yes. Tivoxen may be taken with or without food.
4. How long is one treatment cycle?
Ans: A standard cycle consists of 21 days of treatment followed by 7 days off, totaling 28 days.
5. Can I stop taking Tivoxen if I feel better?
Ans: No. Continue treatment exactly as prescribed and only stop if instructed by your oncologist.
Final Thoughts
Tivoxen 1.34 MG (Tivozanib) represents a significant advancement in the treatment of advanced renal cell carcinoma. By selectively blocking VEGF receptors, it reduces the blood supply that tumors need to grow, helping slow disease progression while offering the convenience of once-daily oral therapy.
Although Tivoxen can cause side effects, careful monitoring and regular follow-up with your oncology team can help manage these risks effectively.
If you’re looking for a trusted source to obtain Tivoxen 1.34 MG, Unit Pharmacy is committed to providing authentic oncology medicines, dependable worldwide delivery, and compassionate support throughout your treatment journey. Always consult your oncologist to determine whether Tivoxen is appropriate for your specific medical condition and treatment plan.
Reviews
There are no reviews yet.